Report interim data from AAVIATE Cohort 1
Delivered after the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 5 Jan 2021
- Due
- 30 Sep 2021
- Delivered
- October 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“REGENXBIO plans to report interim data from Cohort 1 in the third quarter of 2021.”
What we found
Evidence strength A What the grades mean
The company announced it would report interim data in the third quarter of 2021, but the filings indicate the data was presented in October 2021, which is in the fourth quarter.
-
A Regenxbio Inc. 8-K filed 2021-11-02
“In October 2021, REGENXBIO presented positive initial data from patients enrolled in the ongoing Phase II AAVIATE® trial.” ✓ confirmed on the page
Market reaction: the shares moved +5.1% against the S&P 500 over the three sessions around the disclosure (1 Nov 2021 to 4 Nov 2021). What this measures
Checked 24 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Report
- Deliverable
- AAVIATE Cohort 1 interim data
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Regenxbio Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-RGNX-021061 · Corrections policy